61Indexed trials
Market Rank #38 · Evidence Tier A
Chile
Neuroscience Intelligence
Chile neuroscience intelligence: 61 indexed trials, 6 institutions, research score 26.05.
16Recruiting
6Research institutions
26.1Research score
Evidence profile
29Sponsors
15Disease areas
0Institution works
0Institution citations
Model signals
Opportunity 26 · ML priority 26 · Confidence 85 · Evidence 26.1
These are comparative evidence signals. They do not represent a guarantee of market size or commercial outcome.
Leading disease areas
parkinsons21trials
alzheimers7trials
epilepsy5trials
depression4trials
anxiety3trials
bipolar_disorder2trials
pain_neuropathy2trials
stroke2trials
other_psychiatry2trials
neuroimmunology1trials
Leading indexed sponsors
Merck Sharp & Dohme LLC20trials
Pfizer5trials
GlaxoSmithKline3trials
Hoffmann-La Roche3trials
Pontificia Universidad Catolica de Chile3trials
Xenon Pharmaceuticals Inc.2trials
Novartis Pharmaceuticals2trials
AbbVie2trials
CanSino Biologics Inc.1trials
Boehringer Ingelheim1trials